Import safety summit
This article was originally published in The Tan Sheet
Executive SummaryFDA Commissioner Andrew von Eschenbach will moderate a discussion on the legal and regulatory safety and security requirements for the drug industry at the Import Safety Summit July 9 in Washington, the Consumer Healthcare Products Association announces. The summit, cosponsored by CHPA and other trade and advocacy groups, will include a keynote address by Health and Human Services Secretary Michael Leavitt and sessions on import safety challenges, standard-setting, auditing and certification efforts in an evolving global marketplace...
You may also be interested in...
The US FDA has abandoned all near-term plans to inspect Chinese manufacturing facilities in the wake of the coronavirus crisis. See what agency head Stephen Hahn said about it here.
The company maintains that its products are safe, but plaintiffs in proposed class actions allege it has knowingly put consumers at risk of hair loss and other injuries. DevaCurl’s troubles escalated quickly after a former brand ambassador went viral with a 31 January video urging consumers to stop using DevaCurl products and adopt safer alternatives.
To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.